Orthofix shareholders approve stock purchase plan share increase, elect directors

Orthofix Medical Inc.

Shareholders approved Amendment No. 5 to Stock Purchase Plan, increasing authorized shares by 1.25M to 6.1M.
All 10 director nominees elected; Burris (24.9M for, 5.2M against) and Paolucci (24.7M for, 5.4M against) had notable opposition.
Advisory vote on executive compensation passed with 24.5M for, 5.6M against (81.4% approval).
Ernst & Young ratified as independent auditor for FY 2026 with 33.3M votes in favor.
Meeting quorum of 34.8M shares (86% of outstanding) present from 40.4M eligible shares.

item 5.02 item 5.07 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 1.0

Orthofix Medical Inc. shareholders approved Election of Board of Directors at the 2026-06-10 meeting.

Proposal: director election
Outcome: passed
Meeting: 2026-06-10

Exact text from the filing

Election of Board of Directors. The following persons were elected as directors of the Company for a one-year term expiring at the 2027 Annual Meeting of Shareholders: Name Votes For Votes Against Abstentions Alan L. Bazaar 29,026,559 1,014,417 31,243 Wayne Burris 24,898,636 5,162,812 10,771 Massimo Calafiore 29,344,227 725,358 2,634 Vickie L. Capps 29,373,109 667,919 31,191 Michael M. Finegan 29,238,156 827,899 6,164 Jason M. Hannon 29,389,134 676,817 6,268 John B. Henneman, III 28,798,930 1,262,304 10,985 Charles R. Kummeth 28,990,854 1,070,316 11,049 Shweta S. Maniar 29,631,030 434,784 6,405 Michael E. Paolucci 24,698,858 5,367,249 6,112

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 1.0

Orthofix Medical Inc. shareholders approved Advisory and Non-Binding Resolution to Approve Executive Compensation at the 2026-06-10 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2026-06-10

Exact text from the filing

Advisory and Non-Binding Resolution to Approve Executive Compensation. The advisory and non-binding resolution to approve executive compensation was approved by a vote of (i) 24,480,474 in favor, (ii) 5,577,200 against, and (iii) 14,545 abstaining.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 1.0

Orthofix Medical Inc. shareholders approved Ratification of the Selection of Ernst & Young LLP at the 2026-06-10 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2026-06-10

Exact text from the filing

Ratification of the Selection of Ernst & Young LLP. The selection of Ernst & Young LLP to act as the independent registered public accounting firm for the Company and its subsidiaries for the fiscal year ending December 31, 2026 was ratified by a vote of (i) 33,262,505 in favor, (ii) 1,384,292 against, and (iii) 129,879 abstaining.

View on SEC.gov

1639 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Orthofix Medical Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-266679

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.